Industry & Policy News

[International Society for Stem Cell Research] The International Society for Stem Cell Research (ISSCR) has announced that it will present this year’s ISSCR Momentum Award to Cédric Blanpain, M.D., Ph.D., professor and director of the laboratory of stem cells and cancer at the Université Libre de Bruxelles, Belgium.

[ENA Respiratory] ENA Respiratory announced that INNA-051, a first-in-class, broad-spectrum, innate immunomodulator in development for the prophylaxis of respiratory viral infections, was found to significantly impact the course of viral infection in a Phase IIa flu challenge study.

[Science] A long-smoldering debate among scientists studying autism erupted. At issue is language—for example, whether researchers should describe autism as a “disorder,” “disability,” or “difference,” and whether its associated features should be called “symptoms” or simply “traits

[UC Davis Health] UC Davis Comprehensive Cancer Center has partnered with TargaGenix and Northeastern University to study PDAC. The academic-industry partnership will receive nearly $3 million over five years thanks to National Institutes of Health funding through its R01 grant program.

[Valo Therapeutics Oy] Valo Therapeutics Oy announced that it has secured funding of approximately EUR 2.23 millionfrom the European Innovation Council for a project to progress the company’s PeptiCHIP technology, which rapidly identifies a tumor’s antigen presentation profile to drive development of novel personalized immunotherapies.

[Grayson-Jockey Club Research Foundation (Past The Wire)] The board of directors of Grayson-Jockey Club Research Foundation announced that it has authorized expenditure of $1,498,077 to fund 12 new projects and nine continuing projects at 13 universities as well as two career development awards.